Repositório Covid-1909/08/2022 Seasonal variation of the composition of essential oils from Piper cernuum Vell and Piper rivinoides Kunth, ADMET study, DFT calculations, molecular docking and dynamics studies of major components as potent inhibitors of the heterodimer methyltransferase complex NSP16-NSP10 SARS COV-2 proteinAbstract09/08/2022 Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for useAbstractPurposeThe absence of specific treatments for COVID-19 leads to an intense global effort in the search for new...09/08/2022 A Multiscale Model of COVID-19 DynamicsAbstractCOVID-19, caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a global pandemic and...09/08/2022 Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19AbstractIt is an urgent demand worldwide to control the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute...09/08/2022 Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational studySummaryBackgroundLimited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in...08/08/2022 Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studySummaryBackgroundLittle is known about vaccine effectiveness over time among adolescents, especially against the SARS-CoV-2 omicron (B.1.1.529) variant. This...04/08/2022 Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine developmentAbstractThe spread of coronavirus diseases has resulted in a clarion call to develop potent drugs and vaccines even as...04/08/2022 Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titerSummaryNeutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,...03/08/2022 Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2AbstractThe unprecedented outbreak of the severe acute respiratory syndrome (SARS) Coronavirus-2, across the globe, triggered a worldwide uproar in...02/08/2022 Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsLara Alzyoud,1 Mohammad A Ghattas,1,2 Noor Atatreh1,229/07/2022 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveysSummaryBackgroundThe Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the...29/07/2022 Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including OmicronAbstractStudying the antibody response to SARS-CoV-2 informs on how the human immune system can respond to antigenic variants as...
09/08/2022 Seasonal variation of the composition of essential oils from Piper cernuum Vell and Piper rivinoides Kunth, ADMET study, DFT calculations, molecular docking and dynamics studies of major components as potent inhibitors of the heterodimer methyltransferase complex NSP16-NSP10 SARS COV-2 proteinAbstract
09/08/2022 Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for useAbstractPurposeThe absence of specific treatments for COVID-19 leads to an intense global effort in the search for new...
09/08/2022 A Multiscale Model of COVID-19 DynamicsAbstractCOVID-19, caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a global pandemic and...
09/08/2022 Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19AbstractIt is an urgent demand worldwide to control the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute...
09/08/2022 Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational studySummaryBackgroundLimited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in...
08/08/2022 Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studySummaryBackgroundLittle is known about vaccine effectiveness over time among adolescents, especially against the SARS-CoV-2 omicron (B.1.1.529) variant. This...
04/08/2022 Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine developmentAbstractThe spread of coronavirus diseases has resulted in a clarion call to develop potent drugs and vaccines even as...
04/08/2022 Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titerSummaryNeutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,...
03/08/2022 Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2AbstractThe unprecedented outbreak of the severe acute respiratory syndrome (SARS) Coronavirus-2, across the globe, triggered a worldwide uproar in...
02/08/2022 Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsLara Alzyoud,1 Mohammad A Ghattas,1,2 Noor Atatreh1,2
29/07/2022 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveysSummaryBackgroundThe Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the...
29/07/2022 Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including OmicronAbstractStudying the antibody response to SARS-CoV-2 informs on how the human immune system can respond to antigenic variants as...